Table-I.
Patient characteristics.
| Number of patients | % | Mean | SD | |
|---|---|---|---|---|
| Age | 48 | 10.34262 | ||
| Group I: Conventional RT | 77 | 77 | ||
| Group II: IMRT | 23 | 23 | ||
| Weight (kg) | 59.19 | 8.305 | ||
| Dose fraction (Gy) | 1.8773 | 0.07536 | ||
| Prior chemotherapy | ||||
| No | 53 | 53 | ||
| Yes | 47 | 47 | ||
| Concurrent chemotherapy | ||||
| No | 85 | 85 | ||
| Yes | 15 | 15 | ||
| Chemotherapy (total) | ||||
| No | 48 | 48 | ||
| Yes | 52 | 52 | ||
| Block | ||||
| No | 45 | 45 | ||
| Yes | 55 | 55 | ||
| Histological feature | ||||
| Squamous carcinoma | 64 | 64 | ||
| Adenocarcinoma | 29 | 29 | ||
| Others | 7 | 7 | ||
| Pelvic LN metastasis | ||||
| Negative | 65 | 65 | ||
| Positive | 17 | 17 | ||
| No scavenge or surgery records lost | 18 | 18 | ||
| Days between surgery and radiation | 173.47 | 570.9225 | ||
| Diabetes | ||||
| No | 97 | 97 | ||
| Yes | 3 | 3 | ||
| Hypertension | ||||
| No | 88 | 88 | ||
| Yes | 12 | 12 | ||
| Transfusion (during surgery) | 25 | 25 |
RT:radiation therapy;
IMRT:intensity-modulated radiation therapy;
LN:lymph nodes.